Nifty
Sensex
:
:
10682.20
35457.16
65.50 (0.62%)
196.62 (0.56%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 532322 | NSE: ELDERPHARM

Not traded in the last 30 days
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  N/A
  •  N/A
  •  N/A
  •  N/A
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  N/A
  •  N/A
  •  N/A
  •  N/A

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 78.04
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 379.05
  • N/A
  • 0.11

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 25.34%
  • 11.16%
  • 22.49%
  • FII
  • DII
  • Others
  • 22.13%
  • 1.85%
  • 17.03%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.72
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.74
  • 0.41
  • 0.17

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.02
  • 2.42
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Jun 14
Jun 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Net Sales
-
1,008.91
1,641.70
1,334.78
965.28
721.60
620.34
551.20
449.25
Net Sales Growth
-
-38.54%
22.99%
38.28%
33.77%
16.32%
12.54%
22.69%
 
Cost Of Goods Sold
-
642.91
836.35
688.53
460.03
320.93
279.28
244.62
203.20
Gross Profit
-
365.99
805.35
646.25
505.25
400.67
341.06
306.58
246.06
GP Margin
-
36.28%
49.06%
48.42%
52.34%
55.53%
54.98%
55.62%
54.77%
Total Expenditure
-
1,088.10
1,368.36
1,135.76
794.76
603.46
522.24
446.14
371.25
Power & Fuel Cost
-
14.90
19.16
15.58
8.55
6.57
6.35
5.15
4.38
% Of Sales
-
1.48%
1.17%
1.17%
0.89%
0.91%
1.02%
0.93%
0.97%
Employee Cost
-
217.90
233.09
179.89
119.06
96.65
83.37
67.21
55.89
% Of Sales
-
21.60%
14.20%
13.48%
12.33%
13.39%
13.44%
12.19%
12.44%
Manufacturing Exp.
-
37.98
44.63
39.70
26.84
44.09
38.47
38.26
31.16
% Of Sales
-
3.76%
2.72%
2.97%
2.78%
6.11%
6.20%
6.94%
6.94%
General & Admin Exp.
-
82.29
114.81
88.47
69.67
59.64
48.26
45.55
38.98
% Of Sales
-
8.16%
6.99%
6.63%
7.22%
8.26%
7.78%
8.26%
8.68%
Selling & Distn. Exp.
-
48.26
95.55
89.10
64.58
54.02
54.53
35.60
31.13
% Of Sales
-
4.78%
5.82%
6.68%
6.69%
7.49%
8.79%
6.46%
6.93%
Miscellaneous Exp.
-
43.85
24.76
34.50
46.03
21.56
11.98
9.75
6.51
% Of Sales
-
4.35%
1.51%
2.58%
4.77%
2.99%
1.93%
1.77%
1.45%
EBITDA
-
-79.19
273.34
199.02
170.52
118.14
98.10
105.06
78.00
EBITDA Margin
-
-7.85%
16.65%
14.91%
17.67%
16.37%
15.81%
19.06%
17.36%
Other Income
-
25.66
32.70
26.54
8.66
8.58
25.04
7.98
7.46
Interest
-
275.63
154.83
101.57
65.51
53.02
41.34
23.83
15.57
Depreciation
-
36.13
44.08
33.98
28.73
17.19
11.52
10.61
8.79
PBT
-
-365.29
107.14
90.01
84.93
56.51
70.28
78.59
61.10
Tax
-
12.52
21.92
19.25
16.86
9.29
7.95
9.93
8.33
Tax Rate
-
209.36%
21.01%
21.04%
20.97%
16.44%
11.31%
12.64%
13.63%
PAT
-
-6.53
82.39
72.26
64.23
49.50
62.33
68.66
52.77
PAT before Minority Interest
-
-6.53
82.39
72.26
63.55
47.22
62.33
68.66
52.77
Minority Interest
-
0.00
0.00
0.00
0.68
2.28
0.00
0.00
0.00
PAT Margin
-
-0.65%
5.02%
5.41%
6.65%
6.86%
10.05%
12.46%
11.75%
PAT Growth
-
-
14.02%
12.50%
29.76%
-20.58%
-9.22%
30.11%
 
Unadjusted EPS
-
-3.18
40.11
35.18
32.55
26.25
33.05
37.09
28.41

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 14
Jun 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Shareholder's Funds
773.35
769.26
700.59
630.66
480.48
392.20
364.62
323.38
Share Capital
20.57
20.57
20.57
20.57
18.89
18.89
18.82
18.60
Total Reserves
752.78
748.70
680.03
610.10
461.59
373.31
343.97
302.35
Non-Current Liabilities
515.08
723.39
603.44
527.47
577.67
504.17
346.77
242.02
Secured Loans
342.26
521.90
440.25
444.13
404.09
334.45
170.43
128.11
Unsecured Loans
146.64
182.03
142.28
65.40
169.77
164.69
171.16
108.41
Long Term Provisions
21.21
16.55
14.28
14.45
0.00
0.00
0.00
0.00
Current Liabilities
999.77
999.83
695.74
580.28
123.77
116.56
86.14
107.66
Trade Payables
96.12
120.45
87.97
47.97
37.87
32.30
32.71
39.11
Other Current Liabilities
420.44
405.86
193.20
194.62
60.71
55.64
29.91
27.34
Short Term Borrowings
264.66
443.51
394.81
322.59
0.00
0.00
0.00
0.00
Short Term Provisions
218.54
30.00
19.75
15.10
25.20
28.62
23.52
41.20
Total Liabilities
2,288.20
2,492.48
1,999.77
1,741.47
1,192.31
1,012.93
797.53
673.06
Net Block
706.99
690.60
706.33
647.52
490.44
171.26
169.17
140.30
Gross Block
1,005.70
950.51
921.98
818.39
560.95
224.87
211.53
172.38
Accumulated Depreciation
298.70
259.91
215.65
170.86
70.52
53.60
42.36
32.08
Non Current Assets
1,364.20
1,613.34
1,121.57
913.67
605.38
472.62
360.75
279.00
Capital Work in Progress
305.38
272.53
191.01
94.98
65.74
252.15
163.36
137.19
Non Current Investment
1.84
1.89
2.27
2.27
49.20
49.20
28.22
1.50
Long Term Loans & Adv.
349.98
648.33
221.96
168.90
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
924.00
879.13
878.21
827.79
586.93
540.31
436.78
394.06
Current Investments
1.27
1.39
18.20
7.95
16.75
1.00
59.69
35.40
Inventories
127.99
245.07
292.93
241.74
143.38
88.11
83.68
93.26
Sundry Debtors
165.68
398.15
341.30
282.48
195.35
177.63
139.55
122.43
Cash & Bank
546.61
103.44
154.00
267.09
78.63
146.42
79.02
57.02
Other Current Assets
82.46
50.11
29.72
13.66
152.83
127.15
74.85
85.94
Short Term Loans & Adv.
24.57
80.98
42.06
14.86
149.37
124.57
70.68
81.99
Net Current Assets
-75.77
-120.69
182.47
247.51
463.17
423.75
350.64
286.40
Total Assets
2,288.20
2,492.47
1,999.78
1,741.46
1,192.31
1,012.93
797.53
673.06

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 14
Jun 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
1,175.41
16.59
14.75
65.74
-90.99
136.08
20.83
70.90
PBT
-365.29
107.14
91.51
81.08
58.79
70.28
78.59
61.10
Adjustment
671.92
164.48
109.33
90.14
65.61
35.46
26.14
16.76
Changes in Working Capital
879.98
-229.85
-164.07
-86.88
-151.88
81.29
-50.86
19.90
Cash after chg. in Working capital
1,186.62
41.76
36.77
84.35
-27.47
187.03
53.87
97.76
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-11.21
-25.17
-22.02
-18.61
-10.50
-9.60
-9.20
-11.29
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-56.05
-63.24
-171.10
-150.67
-161.11
-34.74
-108.34
-87.97
Net Fixed Assets
7.27
-90.25
-157.11
-62.83
-124.12
-102.13
-65.32
Net Investments
0.17
17.19
-10.22
8.80
-15.75
57.97
-24.36
Others
-63.49
9.82
-3.77
-96.64
-21.24
9.42
-18.66
Cash from Financing Activity
-676.18
-3.91
43.26
273.39
184.31
-33.94
109.50
37.57
Net Cash Inflow / Outflow
443.17
-50.56
-113.09
188.46
-67.79
67.41
21.99
20.50
Opening Cash & Equivalents
0.00
0.00
0.00
78.63
146.42
79.02
57.02
36.52
Closing Cash & Equivalent
546.61
103.44
154.00
267.09
78.63
146.42
79.02
57.02

Financial Ratios

Standalone /

Consolidated
Description
Jun 14
Jun 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Book Value (Rs.)
376.55
374.56
341.12
307.07
254.78
207.97
193.04
172.80
ROA
-0.27%
3.67%
3.86%
4.33%
4.28%
6.89%
9.34%
7.84%
ROE
-0.85%
11.21%
10.86%
11.44%
10.82%
16.51%
20.08%
16.44%
ROCE
15.08%
13.31%
11.66%
11.29%
11.26%
13.97%
16.18%
13.69%
Fixed Asset Turnover
1.04
1.77
1.55
1.41
1.85
2.89
2.95
2.69
Receivable days
101.58
81.60
84.64
89.44
93.46
91.90
84.31
96.38
Inventory Days
67.21
59.37
72.55
72.08
58.01
49.77
56.94
73.42
Payable days
44.08
29.82
23.53
20.28
21.93
24.62
32.69
42.36
Cash Conversion Cycle
124.71
111.15
133.66
141.24
129.54
117.05
108.56
127.43
Total Debt/Equity
1.10
1.75
1.54
1.43
1.19
1.27
0.94
0.74
Interest Cover
1.02
1.67
1.90
2.23
2.07
2.70
4.30
4.92

Annual Reports:

News Update:


No Latest News!

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.